+1 347 708 0418
The Automation in Biopharmaceutical market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Automation in Biopharmaceutical size is estimated to be USD 1307 million in 2026 from USD 1037.9 million in 2020, with a change XX% between 2020 and 2021. The global Automation in Biopharmaceutical market size is expected to grow at a CAGR of 5.9% for the next five years.
Market segmentation
Automation in Biopharmaceutical market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Clinical Stage Automation
Drug Discovery Stage Automation
Market segment by Application, can be divided into
Research and Development
Clinical
Market segment by players, this report covers
Danaher
GE
PerkinElmer
Tecan Trading
Thermo Fisher Scientific
Bruker
Peak Analysis and Automation
Waters
Capsugel
RheoSense
Eirechrom
BioProcess International
Novasep
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Automation in Biopharmaceutical product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Automation in Biopharmaceutical, with revenue, gross margin and global market share of Automation in Biopharmaceutical from 2019 to 2021.
Chapter 3, the Automation in Biopharmaceutical competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Automation in Biopharmaceutical market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Automation in Biopharmaceutical research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Automation in Biopharmaceutical
1.2 Classification of Automation in Biopharmaceutical by Type
1.2.1 Overview: Global Automation in Biopharmaceutical Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Automation in Biopharmaceutical Revenue Market Share by Type in 2020
1.2.3 Clinical Stage Automation
1.2.4 Drug Discovery Stage Automation
1.3 Global Automation in Biopharmaceutical Market by Application
1.3.1 Overview: Global Automation in Biopharmaceutical Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Research and Development
1.3.3 Clinical
1.4 Global Automation in Biopharmaceutical Market Size & Forecast
1.5 Global Automation in Biopharmaceutical Market Size and Forecast by Region
1.5.1 Global Automation in Biopharmaceutical Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Automation in Biopharmaceutical Market Size by Region, (2016-2021)
1.5.3 North America Automation in Biopharmaceutical Market Size and Prospect (2016-2026)
1.5.4 Europe Automation in Biopharmaceutical Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Automation in Biopharmaceutical Market Size and Prospect (2016-2026)
1.5.6 South America Automation in Biopharmaceutical Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Automation in Biopharmaceutical Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Automation in Biopharmaceutical Market Drivers
1.6.2 Automation in Biopharmaceutical Market Restraints
1.6.3 Automation in Biopharmaceutical Trends Analysis
2 Company Profiles
2.1 Danaher
2.1.1 Danaher Details
2.1.2 Danaher Major Business
2.1.3 Danaher Automation in Biopharmaceutical Product and Solutions
2.1.4 Danaher Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Danaher Recent Developments and Future Plans
2.2 GE
2.2.1 GE Details
2.2.2 GE Major Business
2.2.3 GE Automation in Biopharmaceutical Product and Solutions
2.2.4 GE Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 GE Recent Developments and Future Plans
2.3 PerkinElmer
2.3.1 PerkinElmer Details
2.3.2 PerkinElmer Major Business
2.3.3 PerkinElmer Automation in Biopharmaceutical Product and Solutions
2.3.4 PerkinElmer Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 PerkinElmer Recent Developments and Future Plans
2.4 Tecan Trading
2.4.1 Tecan Trading Details
2.4.2 Tecan Trading Major Business
2.4.3 Tecan Trading Automation in Biopharmaceutical Product and Solutions
2.4.4 Tecan Trading Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Tecan Trading Recent Developments and Future Plans
2.5 Thermo Fisher Scientific
2.5.1 Thermo Fisher Scientific Details
2.5.2 Thermo Fisher Scientific Major Business
2.5.3 Thermo Fisher Scientific Automation in Biopharmaceutical Product and Solutions
2.5.4 Thermo Fisher Scientific Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.6 Bruker
2.6.1 Bruker Details
2.6.2 Bruker Major Business
2.6.3 Bruker Automation in Biopharmaceutical Product and Solutions
2.6.4 Bruker Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Bruker Recent Developments and Future Plans
2.7 Peak Analysis and Automation
2.7.1 Peak Analysis and Automation Details
2.7.2 Peak Analysis and Automation Major Business
2.7.3 Peak Analysis and Automation Automation in Biopharmaceutical Product and Solutions
2.7.4 Peak Analysis and Automation Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Peak Analysis and Automation Recent Developments and Future Plans
2.8 Waters
2.8.1 Waters Details
2.8.2 Waters Major Business
2.8.3 Waters Automation in Biopharmaceutical Product and Solutions
2.8.4 Waters Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Waters Recent Developments and Future Plans
2.9 Capsugel
2.9.1 Capsugel Details
2.9.2 Capsugel Major Business
2.9.3 Capsugel Automation in Biopharmaceutical Product and Solutions
2.9.4 Capsugel Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Capsugel Recent Developments and Future Plans
2.10 RheoSense
2.10.1 RheoSense Details
2.10.2 RheoSense Major Business
2.10.3 RheoSense Automation in Biopharmaceutical Product and Solutions
2.10.4 RheoSense Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 RheoSense Recent Developments and Future Plans
2.11 Eirechrom
2.11.1 Eirechrom Details
2.11.2 Eirechrom Major Business
2.11.3 Eirechrom Automation in Biopharmaceutical Product and Solutions
2.11.4 Eirechrom Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Eirechrom Recent Developments and Future Plans
2.12 BioProcess International
2.12.1 BioProcess International Details
2.12.2 BioProcess International Major Business
2.12.3 BioProcess International Automation in Biopharmaceutical Product and Solutions
2.12.4 BioProcess International Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 BioProcess International Recent Developments and Future Plans
2.13 Novasep
2.13.1 Novasep Details
2.13.2 Novasep Major Business
2.13.3 Novasep Automation in Biopharmaceutical Product and Solutions
2.13.4 Novasep Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Novasep Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Automation in Biopharmaceutical Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Automation in Biopharmaceutical Players Market Share
3.2.2 Top 10 Automation in Biopharmaceutical Players Market Share
3.2.3 Market Competition Trend
3.3 Automation in Biopharmaceutical Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Automation in Biopharmaceutical Revenue and Market Share by Type (2016-2021)
4.2 Global Automation in Biopharmaceutical Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Automation in Biopharmaceutical Revenue Market Share by Application (2016-2021)
5.2 Automation in Biopharmaceutical Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Automation in Biopharmaceutical Revenue by Type (2016-2026)
6.2 North America Automation in Biopharmaceutical Revenue by Application (2016-2026)
6.3 North America Automation in Biopharmaceutical Market Size by Country
6.3.1 North America Automation in Biopharmaceutical Revenue by Country (2016-2026)
6.3.2 United States Automation in Biopharmaceutical Market Size and Forecast (2016-2026)
6.3.3 Canada Automation in Biopharmaceutical Market Size and Forecast (2016-2026)
6.3.4 Mexico Automation in Biopharmaceutical Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Automation in Biopharmaceutical Revenue by Type (2016-2026)
7.2 Europe Automation in Biopharmaceutical Revenue by Application (2016-2026)
7.3 Europe Automation in Biopharmaceutical Market Size by Country
7.3.1 Europe Automation in Biopharmaceutical Revenue by Country (2016-2026)
7.3.2 Germany Automation in Biopharmaceutical Market Size and Forecast (2016-2026)
7.3.3 France Automation in Biopharmaceutical Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Automation in Biopharmaceutical Market Size and Forecast (2016-2026)
7.3.5 Russia Automation in Biopharmaceutical Market Size and Forecast (2016-2026)
7.3.6 Italy Automation in Biopharmaceutical Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Automation in Biopharmaceutical Revenue by Type (2016-2026)
8.2 Asia-Pacific Automation in Biopharmaceutical Revenue by Application (2016-2026)
8.3 Asia-Pacific Automation in Biopharmaceutical Market Size by Region
8.3.1 Asia-Pacific Automation in Biopharmaceutical Revenue by Region (2016-2026)
8.3.2 China Automation in Biopharmaceutical Market Size and Forecast (2016-2026)
8.3.3 Japan Automation in Biopharmaceutical Market Size and Forecast (2016-2026)
8.3.4 South Korea Automation in Biopharmaceutical Market Size and Forecast (2016-2026)
8.3.5 India Automation in Biopharmaceutical Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Automation in Biopharmaceutical Market Size and Forecast (2016-2026)
8.3.7 Australia Automation in Biopharmaceutical Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Automation in Biopharmaceutical Revenue by Type (2016-2026)
9.2 South America Automation in Biopharmaceutical Revenue by Application (2016-2026)
9.3 South America Automation in Biopharmaceutical Market Size by Country
9.3.1 South America Automation in Biopharmaceutical Revenue by Country (2016-2026)
9.3.2 Brazil Automation in Biopharmaceutical Market Size and Forecast (2016-2026)
9.3.3 Argentina Automation in Biopharmaceutical Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Automation in Biopharmaceutical Revenue by Type (2016-2026)
10.2 Middle East & Africa Automation in Biopharmaceutical Revenue by Application (2016-2026)
10.3 Middle East & Africa Automation in Biopharmaceutical Market Size by Country
10.3.1 Middle East & Africa Automation in Biopharmaceutical Revenue by Country (2016-2026)
10.3.2 Turkey Automation in Biopharmaceutical Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Automation in Biopharmaceutical Market Size and Forecast (2016-2026)
10.3.4 UAE Automation in Biopharmaceutical Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Automation in Biopharmaceutical Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Automation in Biopharmaceutical Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Automation in Biopharmaceutical Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Automation in Biopharmaceutical Revenue (USD Million) by Region (2016-2021)
Table 5. Global Automation in Biopharmaceutical Revenue Market Share by Region (2021-2026)
Table 6. Danaher Corporate Information, Head Office, and Major Competitors
Table 7. Danaher Major Business
Table 8. Danaher Automation in Biopharmaceutical Product and Solutions
Table 9. Danaher Automation in Biopharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. GE Corporate Information, Head Office, and Major Competitors
Table 11. GE Major Business
Table 12. GE Automation in Biopharmaceutical Product and Solutions
Table 13. GE Automation in Biopharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. PerkinElmer Corporate Information, Head Office, and Major Competitors
Table 15. PerkinElmer Major Business
Table 16. PerkinElmer Automation in Biopharmaceutical Product and Solutions
Table 17. PerkinElmer Automation in Biopharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Tecan Trading Corporate Information, Head Office, and Major Competitors
Table 19. Tecan Trading Major Business
Table 20. Tecan Trading Automation in Biopharmaceutical Product and Solutions
Table 21. Tecan Trading Automation in Biopharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 23. Thermo Fisher Scientific Major Business
Table 24. Thermo Fisher Scientific Automation in Biopharmaceutical Product and Solutions
Table 25. Thermo Fisher Scientific Automation in Biopharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Bruker Corporate Information, Head Office, and Major Competitors
Table 27. Bruker Major Business
Table 28. Bruker Automation in Biopharmaceutical Product and Solutions
Table 29. Bruker Automation in Biopharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Peak Analysis and Automation Corporate Information, Head Office, and Major Competitors
Table 31. Peak Analysis and Automation Major Business
Table 32. Peak Analysis and Automation Automation in Biopharmaceutical Product and Solutions
Table 33. Peak Analysis and Automation Automation in Biopharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Waters Corporate Information, Head Office, and Major Competitors
Table 35. Waters Major Business
Table 36. Waters Automation in Biopharmaceutical Product and Solutions
Table 37. Waters Automation in Biopharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Capsugel Corporate Information, Head Office, and Major Competitors
Table 39. Capsugel Major Business
Table 40. Capsugel Automation in Biopharmaceutical Product and Solutions
Table 41. Capsugel Automation in Biopharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. RheoSense Corporate Information, Head Office, and Major Competitors
Table 43. RheoSense Major Business
Table 44. RheoSense Automation in Biopharmaceutical Product and Solutions
Table 45. RheoSense Automation in Biopharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Eirechrom Corporate Information, Head Office, and Major Competitors
Table 47. Eirechrom Major Business
Table 48. Eirechrom Automation in Biopharmaceutical Product and Solutions
Table 49. Eirechrom Automation in Biopharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. BioProcess International Corporate Information, Head Office, and Major Competitors
Table 51. BioProcess International Major Business
Table 52. BioProcess International Automation in Biopharmaceutical Product and Solutions
Table 53. BioProcess International Automation in Biopharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Novasep Corporate Information, Head Office, and Major Competitors
Table 55. Novasep Major Business
Table 56. Novasep Automation in Biopharmaceutical Product and Solutions
Table 57. Novasep Automation in Biopharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global Automation in Biopharmaceutical Revenue (USD Million) by Players (2019-2021)
Table 59. Global Automation in Biopharmaceutical Revenue Share by Players (2019-2021)
Table 60. Breakdown of Automation in Biopharmaceutical by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Automation in Biopharmaceutical Players Head Office, Products and Services Provided
Table 62. Automation in Biopharmaceutical Mergers & Acquisitions in the Past Five Years
Table 63. Automation in Biopharmaceutical New Entrants and Expansion Plans
Table 64. Global Automation in Biopharmaceutical Revenue (USD Million) by Type (2016-2021)
Table 65. Global Automation in Biopharmaceutical Revenue Share by Type (2016-2021)
Table 66. Global Automation in Biopharmaceutical Revenue Forecast by Type (2021-2026)
Table 67. Global Automation in Biopharmaceutical Revenue by Application (2016-2021)
Table 68. Global Automation in Biopharmaceutical Revenue Forecast by Application (2021-2026)
Table 69. North America Automation in Biopharmaceutical Revenue by Type (2016-2021) & (USD Million)
Table 70. North America Automation in Biopharmaceutical Revenue by Type (2021-2026) & (USD Million)
Table 71. North America Automation in Biopharmaceutical Revenue by Application (2016-2021) & (USD Million)
Table 72. North America Automation in Biopharmaceutical Revenue by Application (2021-2026) & (USD Million)
Table 73. North America Automation in Biopharmaceutical Revenue by Country (2016-2021) & (USD Million)
Table 74. North America Automation in Biopharmaceutical Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe Automation in Biopharmaceutical Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe Automation in Biopharmaceutical Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe Automation in Biopharmaceutical Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe Automation in Biopharmaceutical Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe Automation in Biopharmaceutical Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe Automation in Biopharmaceutical Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific Automation in Biopharmaceutical Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific Automation in Biopharmaceutical Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Automation in Biopharmaceutical Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific Automation in Biopharmaceutical Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Automation in Biopharmaceutical Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific Automation in Biopharmaceutical Revenue by Region (2021-2026) & (USD Million)
Table 87. South America Automation in Biopharmaceutical Revenue by Type (2016-2021) & (USD Million)
Table 88. South America Automation in Biopharmaceutical Revenue by Type (2021-2026) & (USD Million)
Table 89. South America Automation in Biopharmaceutical Revenue by Application (2016-2021) & (USD Million)
Table 90. South America Automation in Biopharmaceutical Revenue by Application (2021-2026) & (USD Million)
Table 91. South America Automation in Biopharmaceutical Revenue by Country (2016-2021) & (USD Million)
Table 92. South America Automation in Biopharmaceutical Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa Automation in Biopharmaceutical Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa Automation in Biopharmaceutical Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Automation in Biopharmaceutical Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa Automation in Biopharmaceutical Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Automation in Biopharmaceutical Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa Automation in Biopharmaceutical Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Automation in Biopharmaceutical Picture
Figure 2. Global Automation in Biopharmaceutical Revenue Market Share by Type in 2020
Figure 3. Clinical Stage Automation
Figure 4. Drug Discovery Stage Automation
Figure 5. Automation in Biopharmaceutical Revenue Market Share by Application in 2020
Figure 6. Research and Development Picture
Figure 7. Clinical Picture
Figure 8. Global Automation in Biopharmaceutical Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 9. Global Automation in Biopharmaceutical Revenue and Forecast (2016-2026) & (USD Million)
Figure 10. Global Automation in Biopharmaceutical Revenue Market Share by Region (2016-2026)
Figure 11. Global Automation in Biopharmaceutical Revenue Market Share by Region in 2020
Figure 12. North America Automation in Biopharmaceutical Revenue (USD Million) and Growth Rate (2016-2026)
Figure 13. Europe Automation in Biopharmaceutical Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Asia-Pacific Automation in Biopharmaceutical Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. South America Automation in Biopharmaceutical Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Middle East and Africa Automation in Biopharmaceutical Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Automation in Biopharmaceutical Market Drivers
Figure 18. Automation in Biopharmaceutical Market Restraints
Figure 19. Automation in Biopharmaceutical Market Trends
Figure 20. Danaher Recent Developments and Future Plans
Figure 21. GE Recent Developments and Future Plans
Figure 22. PerkinElmer Recent Developments and Future Plans
Figure 23. Tecan Trading Recent Developments and Future Plans
Figure 24. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 25. Bruker Recent Developments and Future Plans
Figure 26. Peak Analysis and Automation Recent Developments and Future Plans
Figure 27. Waters Recent Developments and Future Plans
Figure 28. Capsugel Recent Developments and Future Plans
Figure 29. RheoSense Recent Developments and Future Plans
Figure 30. Eirechrom Recent Developments and Future Plans
Figure 31. BioProcess International Recent Developments and Future Plans
Figure 32. Novasep Recent Developments and Future Plans
Figure 33. Global Automation in Biopharmaceutical Revenue Share by Players in 2020
Figure 34. Automation in Biopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Automation in Biopharmaceutical Revenue Market Share in 2020
Figure 36. Global Top 10 Players Automation in Biopharmaceutical Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Automation in Biopharmaceutical Revenue Share by Type in 2020
Figure 39. Global Automation in Biopharmaceutical Market Share Forecast by Type (2021-2026)
Figure 40. Global Automation in Biopharmaceutical Revenue Share by Application in 2020
Figure 41. Global Automation in Biopharmaceutical Market Share Forecast by Application (2021-2026)
Figure 42. North America Automation in Biopharmaceutical Sales Market Share by Type (2016-2026)
Figure 43. North America Automation in Biopharmaceutical Sales Market Share by Application (2016-2026)
Figure 44. North America Automation in Biopharmaceutical Revenue Market Share by Country (2016-2026)
Figure 45. United States Automation in Biopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Automation in Biopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Automation in Biopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Automation in Biopharmaceutical Sales Market Share by Type (2016-2026)
Figure 49. Europe Automation in Biopharmaceutical Sales Market Share by Application (2016-2026)
Figure 50. Europe Automation in Biopharmaceutical Revenue Market Share by Country (2016-2026)
Figure 51. Germany Automation in Biopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Automation in Biopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Automation in Biopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Automation in Biopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Automation in Biopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Automation in Biopharmaceutical Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Automation in Biopharmaceutical Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Automation in Biopharmaceutical Revenue Market Share by Region (2016-2026)
Figure 59. China Automation in Biopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Automation in Biopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Automation in Biopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Automation in Biopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Automation in Biopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Automation in Biopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Automation in Biopharmaceutical Sales Market Share by Type (2016-2026)
Figure 66. South America Automation in Biopharmaceutical Sales Market Share by Application (2016-2026)
Figure 67. South America Automation in Biopharmaceutical Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Automation in Biopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Automation in Biopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Automation in Biopharmaceutical Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Automation in Biopharmaceutical Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Automation in Biopharmaceutical Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Automation in Biopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Automation in Biopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Automation in Biopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
Buy
